Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amedisys, Inc.
  6. Summary
    AMED   US0234361089

AMEDISYS, INC.

(AMED)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/02/2021 12/03/2021 12/06/2021 12/07/2021 12/08/2021 Date
141.62(c) 136.32(c) 144.46(c) 152.18(c) 157.45(c) Last
862 041 428 005 673 143 393 114 457 861 Volume
+3.60% -3.74% +5.97% +5.34% +3.46% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 206 M - -
Net income 2021 214 M - -
Net Debt 2021 203 M - -
P/E ratio 2021 24,3x
Yield 2021 -
Sales 2022 2 374 M - -
Net income 2022 192 M - -
Net Debt 2022 70,4 M - -
P/E ratio 2022 27,2x
Yield 2022 -
Capitalization 5 133 M 5 133 M -
EV / Sales 2021 2,42x
EV / Sales 2022 2,19x
Nbr of Employees 21 000
Free-Float 85,3%
More Financials
Company
Amedisys, Inc. is a healthcare services company. The Company is a multi-state provider of home health, hospice, and personal care services. The Company operates through three segments: Home Health, Hospice and Personal Care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with... 
More about the company
Ratings of Amedisys, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about AMEDISYS, INC.
12/08AMEDISYS INC : Regulation FD Disclosure (form 8-K)
AQ
11/30Amedisys to Present at the Bank of America Securities 2021 Virtual Healthcare Conferenc..
GL
11/19Amedisys to Present at the Stephens Annual Investment Conference
GL
11/19Amedisys to Present at the Stephens Annual Investment Conference
GL
11/10Penn State Health Partners with Highmark Health and Contessa to Launch Home Recovery Ca..
PU
11/10AMEDISYS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
11/10Penn State Health Partners with Highmark Health and Contessa to Launch Home Recovery Ca..
PR
11/09BMO Capital Adjusts Amedisys PT to $210 From $200, Maintains Market Perform Rating
MT
11/08Raymond James Adjusts Price Target on Amedisys to $225 from $250, Keeps Outperform Rati..
MT
11/05UBS Adjusts Price Target on Amedisys to $152 From $150, Maintains Sell Rating
MT
11/05Deutsche Bank Adjusts Amedisys PT to $230 From $250, Maintains Buy Rating
MT
11/04Amedisys to Present at the Jefferies London Healthcare Conference
AQ
11/04Credit Suisse Adjusts Amedisys' Price Target to $205 from $192, Keeps Outperform Rating
MT
11/04Stephens Adjusts Amedisys' Price Target to $185 from $178, Keeps Equalweight Rating
MT
11/04SVB Leerink Adjusts Amedisys' Price Target to $181 from $170, Keeps Market Perform Rati..
MT
More news
News in other languages on AMEDISYS, INC.
11/02Amedisys annonce un bénéfice ajusté plus faible au troisième trimestre malgré une hauss..
10/20Amedisys acquiert des actifs réglementaires afin de desservir entièrement et d'étendre ..
09/07VENTE D'INITIÉS : Amedisys
08/05MISE À JOUR SECTORIELLE : Les actions du secteur de la santé réduisent leurs pertes en fin..
08/05MISE À JOUR SECTORIELLE : Les actions du secteur de la santé chutent jeudi, tandis que les..
More news
Analyst Recommendations on AMEDISYS, INC.
More recommendations
Chart AMEDISYS, INC.
Duration : Period :
Amedisys, Inc. Technical Analysis Chart | AMED | US0234361089 | MarketScreener
Technical analysis trends AMEDISYS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 157,45 $
Average target price 205,60 $
Spread / Average Target 30,6%
EPS Revisions
Managers and Directors
Paul B. K. Kusserow Chairman & Chief Executive Officer
Christopher T. Gerard President & Chief Operating Officer
Scott G. Ginn Chief Financial Officer & Executive Vice President
Michael P. North Chief Information Officer
Denise M. Bohnert Chief Compliance Officer
Sector and Competitors